Price Alert

Theriva Biologics Inc. (TOVX)

AMEX: TOVX · Real-Time Price · USD

0.49

-0.02 (-3.54%)

At close: Jul 24, 2025, 3:59 PM

Theriva Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	10.01M	11.61M	16.41M	16.59M	18.26M	23.18M	31.16M	34.25M	36.08M	41.79M	50.49M	52.27M	56.69M	67.33M	72.14M	74.29M	76.89M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	99K	99K	102K	97K	100K	100K	99K	90K	96K	103K	n/a	n/a	n/a	n/a
Other Long-Term Assets	18.26M	171K	182K	77K	-19.24M	78K	173K	123K	123K	-3.15M	113K	119K	126K	23K	23K	23K	23K
Receivables	n/a	3.32M	2M	1.93M	1.91M	1.94M	1.57M	290K	233K	231K	214K	278K	1.72M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	-1.57M	-290K	-233K	-231K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.46M	235K	286K	271K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	12.48M	16.28M	19.53M	19.71M	21.66M	27.4M	34.77M	37.97M	40.3M	45.52M	52.73M	54.89M	59.55M	68.86M	73.56M	75.63M	78.64M
Property-Plant & Equipment	1.42M	1.54M	1.74M	1.85M	2.01M	2.18M	2.22M	2.26M	2.38M	1.54M	1.51M	1.58M	1.64M	1.48M	1.54M	1.6M	395K
Goodwill & Intangibles	n/a	17.36M	18.65M	20.64M	24.89M	25.45M	24.39M	25.1M	25.09M	24.68M	24.34M	25.75M	27.68M	n/a	n/a	n/a	n/a
Total Long-Term Assets	19.68M	19.07M	20.57M	22.68M	27.07M	32.81M	26.78M	27.48M	27.59M	26.34M	25.96M	27.44M	29.45M	1.51M	1.56M	1.62M	418K
Total Assets	32.16M	35.35M	40.11M	42.39M	48.73M	60.21M	61.55M	65.45M	67.89M	71.86M	78.69M	82.33M	89M	70.36M	75.12M	77.25M	79.05M
Account Payables	437K	859K	756K	935K	571K	770K	833K	741K	480K	915K	770K	1M	1.35M	524K	1.25M	568K	621K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.9M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	619K	600K	65K	62K	560K	550K	526K	519K	503K	273K	52K	56K	68K	n/a	n/a	n/a	n/a
Other Current Liabilities	7.09M	1.8M	2.21M	1.85M	3.71M	3.41M	5.65M	4.88M	6.55M	4.25M	9.48M	9.3M	7.47M	1.93M	n/a	n/a	n/a
Total Current Liabilities	8.15M	7.58M	7.32M	6.85M	6.01M	6.74M	8.74M	9.13M	8.62M	7.06M	13.19M	13.26M	10.98M	3.55M	3.16M	2.1M	2.12M
Long-Term Debt	732K	92K	98K	93K	159K	162K	150K	153K	160K	221K	202K	216K	229K	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	7.78M	6.97M	6.79M	6.64M	6.48M	7.18M	6.81M	5.77M	5.41M	7.21M	2.42M	2.37M	4.69M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	8.52M	8.7M	8.15M	7.9M	8.6M	13.78M	8.92M	8.56M	8.68M	10.24M	7.35M	7.39M	10M	1.4M	1.4M	1.43M	108K
Total Liabilities	16.66M	16.29M	15.47M	14.74M	14.61M	20.51M	17.66M	17.7M	17.3M	17.3M	20.55M	20.66M	20.97M	4.96M	4.56M	3.52M	2.23M
Total Debt	1.35M	1.56M	1.74M	1.83M	2.02M	2.15M	2.22M	2.36M	2.46M	1.68M	1.66M	1.7M	1.77M	1.53M	1.58M	1.62M	405K
Book Value	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Book Value Per Share	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	3K	3K	3K	23K	18K	18K	18K	18K	16K	16K	16K	16K	158K	132K	132K	132K	132K
Retained Earnings	-339.3M	-334.97M	-330.52M	-322.8M	-314.48M	-309.32M	-303.83M	-300.53M	-295.45M	-290.97M	-285.38M	-280.52M	-275.56M	-271.28M	-266.02M	-262.75M	-259.55M
Comprehensive Income	-524K	-1.18M	112K	-709K	-537K	32K	-1.06M	-356K	-305K	-679K	-2.84M	-1.32M	181K	n/a	n/a	n/a	n/a
Shareholders Equity	15.5M	19.07M	24.64M	27.65M	34.12M	39.7M	43.88M	47.75M	50.59M	54.56M	58.15M	61.67M	68.03M	65.41M	73.33M	76.5M	79.6M
Total Investments	n/a	n/a	n/a	99K	99K	102K	97K	100K	100K	99K	90K	96K	103K	n/a	n/a	n/a	n/a